机构：[1]School of Medicine, Sichuan Cancer Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China四川省人民医院四川省肿瘤医院[2]Biochemistry and Molecular Biology, Sichuan Cancer Institute, Chengdu, China四川省肿瘤医院[3]Department of Gynecologic Oncology, Sichuan Cancer Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China四川省肿瘤医院[4]Department of Ultrasound, Sichuan Cancer Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China四川省人民医院四川省肿瘤医院
第一作者机构：[1]School of Medicine, Sichuan Cancer Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
通讯作者：
通讯机构：[3]Department of Gynecologic Oncology, Sichuan Cancer Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
推荐引用方式(GB/T 7714)：
Mei H. J.,Li M.,Zhang G.,et al.Modified sialoglycan by neuraminidase promotes tumor immunity against epithelial ovarian cancer[J].ANNALS OF ONCOLOGY.2021,32:S365-S365.doi:10.1016/j.annonc.2021.08.293.
APA：
Mei, H. J.,Li, M.,Zhang, G.,Zhu, Y.&Huang, J..(2021).Modified sialoglycan by neuraminidase promotes tumor immunity against epithelial ovarian cancer.ANNALS OF ONCOLOGY,32,
MLA：
Mei, H. J.,et al."Modified sialoglycan by neuraminidase promotes tumor immunity against epithelial ovarian cancer".ANNALS OF ONCOLOGY 32.(2021):S365-S365
医学